Glenmark Pharmaceuticals Gains FDA Nod for Progesterone
ELMWOOD PARK, New Jersey, April 9, 2026 Glenmark Pharmaceuticals Limited has received final approval from the U.S. Food and...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
ELMWOOD PARK, New Jersey, April 9, 2026 Glenmark Pharmaceuticals Limited has received final approval from the U.S. Food and...
MILFORD, Mass., April 8, 2026 Waters Corporation has announced U.S. FDA clearance for its Onclarity™ HPV Self-Collection Kit, enabling...
MOUNTAIN LAKES, NEW JERSEY, USA | March 24, 2026 LiviWell, a women’s health innovation company, has announced U.S. FDA...
AMSTERDAM, Netherlands — November 27, 2025. Arletta Pharma Solutions, formerly known as Freya Pharma Solutions, has unveiled a major...
SAN DIEGO, Oct. 1, 2025 — Evofem Biosciences announced that its Middle East partner has submitted an application to...
Berlin, Germany – September 19, 2025 — Bayer announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
SHANGHAI, China & JERSEY CITY, NJ – September 19, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN)...
